Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS)
Targeted therapy initiation for PsA reduced the use of associated treatment and healthcare, with TNFi having a slightly greater effect than IL17i and IL12/23i, except for methotrexate discontinuation.
Authors
- Laura Pina Vegas (ORCID: https://orcid.org/0000-0002-2735-1148)
- Pascal Claudepierre (ORCID: https://orcid.org/0000-0003-1911-0544)
- É. Sbidian (ORCID: https://orcid.org/0000-0002-1267-5270)
- S. Iggui
Institutions
- Inserm (FR)
- Université Paris-Est Créteil (FR)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Centre d’Investigation Clinique 1436 (FR)
Publication Details
- Journal
- RMD Open
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1136/rmdopen-2024-004631
- Citations
- 1
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.47